Soy offers no protection against advanced prostate cancer.
Ads by Google
Prostate Cancer Treatment and Symptoms
Improving access to healthcare system may benefit African-American prostate cancer patients more than educational or motivational interventions, according to a new study.
Decreasing the rates of prostate cancer among black men may require improving access to routine health care, rather than increased education about the disease.
A component of green tea, combined with low doses of the cox2 inhibitor painkiller Celebrex, may be able to slow prostate cancer growth.
Men with prostate cancer have a slightly better long-term side effects profile with radiation seed implants than they do with surgery.
Androgen deprivation therapy, one of the most common treatments for prostate cancer, may increase the risk of death from heart disease in patients over age 65.
The patients received the seed implants as the sole treatment for prostate cancer with no additional chemotherapy or radiation therapy.
Tomatoes and broccoli, two vegetables known for their cancer fighting qualities, are better at shrinking prostate tumors when both are part of the daily diet than when they're eaten alone.
The risk of dying from prostate cancer is higher if you have excess weight or as an adult you gain weight. Obesity increases the risk of death from prostate cancer.
The prostate specific antigen cancer screening test is falsely lowered by a factor of two in middle aged men who have taken Propecia.
Among a group of men in Israel, men with only daughters had a 40 percent higher risk of prostate cancer than men with at least one son.
Study of 70,000 men finds men who lose weight may reduce their risk of prostate cancer.
The financial burden related to prostate cancer management over five years is substantial and sustained.
Elderly men who received treatment for localized prostate cancer survived significantly longer than men who did not receive treatment.
84 percent of GPs and 76 percent of specialists agree that there is a significant legal risk associated with off label prescribing in prostate cancer when there is a licensed alternative available.
Men who received prostate cancer treatment were 31 percent less likely to die.
African Americans with prostate cancer more likely to have family history of prostate, breast cancer.
Men experienced half the risk of developing advanced prostate cancer when using statin drugs.
Male patients are increasingly demanding PSA tests for prostate cancer, despite lack of evidence that they are effective.
Using a protein made by prostate cancer scientists have found a way to target and kill the cancer cells themselves.
The hope is that a drug could be used eventually for prostate cancer treatment in men at high risk of developing prostate cancer and to prevent recurrences in men already treated for primary tumours.
The University of Iowa therapeutic trial may lead to new treatments for men diagnosed with prostate cancer.
Collaborative effort may open doors to improved diagnosis and treatment of prostate cancer.
When interpreting prostate cancer screening test results, physicians should consider the impact of a patient's body mass index, regardless of race.
Aggressive prostate cancer is identified by a new marker.
Results from the largest study of men with prostate cancer treated with high dose, intensity modulated radiation therapy (IMRT) show that the majority of patients remain alive with no evidence of disease.
Many patients do not experience early symptoms of prostate cancer, making it important for men who are aged 50 and older to have routine screenings for the disease and treatment.